MedPath

CEPTAZ INJ 10GM/VIAL

CEPTAZ INJ 10GM/VIAL

Discontinued
DIN Number

01968092

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

glaxo canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01968092
AIG Number0116900005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD02 CEFTAZIDIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.06.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFTAZIDIMEActive
Strength: 10 G / VIAL
Monograph: CEFTAZIDIME

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.